Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alcidion GroupASX:ALC +1.03% Debt-to-Equity is 0.01 as of Dec. 2025, which is 50% below its 10-year median of 0.02. The stock has 4 warning signs investors should review. Among 558 Healthcare Providers & Services companies, Alcidion Group ranks better than 99.82% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Alcidion Group's Debt-to-Equity or its related term are showing as below:
ASX:ALC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.03
Current: 0.01
During the past 13 years, the highest Debt-to-Equity Ratio of Alcidion Group was 0.03. The lowest was 0.00. And the median was 0.02.
ASX:ALC's Debt-to-Equity is ranked better than 99.82% of 558
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs ASX:ALC: 0.01
Alcidion Group (ASX:ALC) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Alcidion Group Debt-to-Equity Related Terms
Alcidion Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: Debt-to-Equity Comparison
For the Health Information Services subindustry, Alcidion Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a Debt-to-Equity of 0.01 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alcidion Group and its competitors. This is 50% below median its historical median of 0.02. According to the industry distribution chart, Alcidion Group ranks #1 out of 558 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Alcidion Group's Debt-to-Equity too high?
Alcidion Group's current Debt-to-Equity of 0.01 is 50% below median its 10-year median of 0.02. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Alcidion Group's value of 0.01 is 97.5% below this industry median. Based on the distribution chart, Alcidion Group ranks #1 out of 558 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Alcidion Group's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #1 out of 558 companies for Debt-to-Equity. This places Alcidion Group in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.41. Alcidion Group's value of 0.01 is 97.5% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 0.41, Alcidion Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Debt-to-Equity of 0.01 is 97.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Debt-to-Equity is 0.01, which is 50% below median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 18.3% below its estimated fair value. The current Debt-to-Equity is 0.01, which is 50% below median its 10-year median of 0.02 and 97.5% below the Healthcare Providers & Services industry median of 0.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Debt-to-Equity is 0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
